1. Home
  2. NAMS vs AIR Comparison

NAMS vs AIR Comparison

Compare NAMS & AIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

HOLD

Current Price

$35.16

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Logo AAR Corp.

AIR

AAR Corp.

HOLD

Current Price

$137.34

Market Cap

4.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAMS
AIR
Founded
2019
1951
Country
Netherlands
United States
Employees
100
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.3B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
NAMS
AIR
Price
$35.16
$137.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
5
Target Price
$46.75
$131.20
AVG Volume (30 Days)
1.1M
404.4K
Earning Date
05-06-2026
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
3.59
Revenue
N/A
N/A
Revenue This Year
$17.96
$18.83
Revenue Next Year
$540.65
$10.93
P/E Ratio
N/A
$38.04
Revenue Growth
N/A
N/A
52 Week Low
$20.53
$71.43
52 Week High
$42.21
$146.75

Technical Indicators

Market Signals
Indicator
NAMS
AIR
Relative Strength Index (RSI) 57.72 57.73
Support Level $33.83 $101.48
Resistance Level $37.27 $146.75
Average True Range (ATR) 1.74 5.68
MACD 0.42 -0.99
Stochastic Oscillator 71.19 49.39

Price Performance

Historical Comparison
NAMS
AIR

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

About AIR AAR Corp.

AAR Corp is engaged in providing products and services to aviation, government and defense market. It operates in segments namely: The parts supply segment majorly consists of sales and leasing of USM and aftermarket distribution of new, OEM-supplied replacement parts; Repair & Engineering segment provides airframe maintenance, component repair, and landing gear overhaul services; Integrated Solutions segment consists of its fleet management and operations of customer-owned aircraft, customized performance-based supply chain logistics programs in support of the U.S. Department of Defense, flight hour component inventory; and The Expeditionary Services segment consists of products and services supporting the movement of equipment and personnel by the U.S. and foreign governments and NGOs.

Share on Social Networks: